ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Synthetic biology approaches to improving immunotherapy – Medical Xpress

Continue reading

2018-04-20 Michael Zand NEWS

CRISPR-Cas9. CANCER, tratament personalizat. Cercetătorii, pași uriași – DCNews

DCNewsCRISPR-Cas9. CANCER, tratament personalizat. Cercetătorii, pași uriașiDCNews"Puteți vedea rezultatele, modificările la gene, dar nu neapărat cum ați ajuns acolo, ceea ce este important pentru a se asigura că CRISPR poate fi folosit în sigura… Continue reading

2018-04-20 Michael Zand NEWS

Taconic Biosciences Licenses Easi-CRISPR Tech – GenomeWeb

GlobeNewswire (press release)Taconic Biosciences Licenses Easi-CRISPR TechGenomeWebNEW YORK (GenomeWeb) – Taconic Biosciences said today that it has acquired a worldwide, nonexclusive license to a novel CRISPR genome-editing technology from the Univers… Continue reading

2018-04-20 Michael Zand NEWS

Is This the Key that Unlocks Stem Cell Treatments for MS? – Multiple Sclerosis News Today


Medical Xpress

Synthetic biology approaches to improving immunotherapy
Medical Xpress
The AACR 2018 Meeting in Chicago is ending today and has featured the major new results in cancer treatment and immunotherapy treatments in particular. Immunotherapy, the use of the patient’s own immune system to attack their cancer, has become a hot …

Continue reading

2018-04-20 Michael Zand NEWS

New CRISPR tool allows DNA editing outside of the cell – News-Medical.net

Is This the Key that Unlocks Stem Cell Treatments for MS?
Multiple Sclerosis News Today
Americans who want to treat their MS with a stem cell transplant have a tough road to follow. They’re forced to travel to Russia, Mexico, or somewhere else out of the country and to spend a lot of money to avoid the U.S. Food and Drug Administration’s …

Continue reading

2018-04-20 Michael Zand NEWS

New CRISPR tool allows DNA editing outside of the cell – News-Medical.net


News-Medical.net

New CRISPR tool allows DNA editing outside of the cell
News-Medical.net
According to a study published in the CRISPR Journal, the new tool could enable scientists to extract DNA fragments from human cells, place them in a test tube and quickly make multiple edits to the genetic code. The researchers say this new “cell-free …
The First “Cell-Free” CRISPR Tech Is Here To Personalize Cancer TreatmentFuturism
Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based InnovatorsSeeking Alpha
‘Cell-free’ CRISPR could improve cancer diagnostics, unravel how gene editing worksFierceBiotech
EurekAlert (press release) –Reason (blog) –Gizmodo
all 17 news articles »
Continue reading

2018-04-20 Michael Zand NEWS

Abeona Therapeutics (ABEO) Announces Orphan Drug Designation … – StreetInsider.com

GlobeNewswireAbeona Therapeutics (ABEO) Announces Orphan Drug Designation …StreetInsider.comGet instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Abeona Therapeutics Inc. (NASDAQ: ABEO), a lea… Continue reading

2018-04-20 Michael Zand NEWS

Taconic Biosciences Licenses Easi-CRISPR Technology from the … – PharmiWeb.com (press release)

Taconic Biosciences Licenses Easi-CRISPR Technology from the …PharmiWeb.com (press release)RENSSELAER, N.Y., April 20, 2018 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions… Continue reading

2018-04-20 Michael Zand NEWS
  • 1
  • …
  • 218
  • 219
  • 220
  • 221
  • 222
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

News-Medical.net

New CRISPR tool allows DNA editing outside of the cell
News-Medical.net
According to a study published in the CRISPR Journal, the new tool could enable scientists to extract DNA fragments from human cells, place them in a test tube and quickly make multiple edits to the genetic code. The researchers say this new “cell-free …
The First “Cell-Free” CRISPR Tech Is Here To Personalize Cancer TreatmentFuturism
Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based InnovatorsSeeking Alpha
‘Cell-free’ CRISPR could improve cancer diagnostics, unravel how gene editing worksFierceBiotech
EurekAlert (press release) –Reason (blog) –Gizmodo
all 17 news articles »